198 related articles for article (PubMed ID: 28028527)
1. From conventional therapy toward microRNA-based therapy in acute promyelocytic leukemia.
Ehtesham N; Sharifi M
Adv Biomed Res; 2016; 5():187. PubMed ID: 28028527
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal abnormality of acute promyelocytic leukemia other than
Imataki O; Uemura M
BMC Clin Pathol; 2016; 16():16. PubMed ID: 27708545
[TBL] [Abstract][Full Text] [Related]
3. A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
Careccia S; Mainardi S; Pelosi A; Gurtner A; Diverio D; Riccioni R; Testa U; Pelosi E; Piaggio G; Sacchi A; Lavorgna S; Lo-Coco F; Blandino G; Levrero M; Rizzo MG
Oncogene; 2009 Nov; 28(45):4034-40. PubMed ID: 19749800
[TBL] [Abstract][Full Text] [Related]
4. A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.
Grassilli S; Nika E; Lambertini E; Brugnoli F; Piva R; Capitani S; Bertagnolo V
Cell Oncol (Dordr); 2016 Oct; 39(5):483-489. PubMed ID: 27480083
[TBL] [Abstract][Full Text] [Related]
5. [microRNAs expression profile in acute promyelocytic leukemia cell differentiation induced by all-trans retinoic acid and arsenic trioxide].
Wu Y; Li XF; Yang JH; Liao XY; Chen YZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):546-51. PubMed ID: 22967415
[TBL] [Abstract][Full Text] [Related]
6. Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia.
Drexler HG; Quentmeier H; MacLeod RA; Uphoff CC; Hu ZB
Leuk Res; 1995 Oct; 19(10):681-91. PubMed ID: 7500643
[TBL] [Abstract][Full Text] [Related]
7. [Leukemogenesis and therapy of acute promyelocytic leukemia: from the worse to the most favorable subtype of acute myeloid leukemia].
Korístek Z; Mayer J
Vnitr Lek; 2008; 54(7-8):701-27. PubMed ID: 18780571
[TBL] [Abstract][Full Text] [Related]
8. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
Batzios C; Hayes LA; He SZ; Quach H; McQuilten ZK; Wall M; Campbell LJ
Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661
[TBL] [Abstract][Full Text] [Related]
9. Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.
Kamath GR; Tremblay D; Coltoff A; Caro J; Lancman G; Bhalla S; Najfeld V; Mascarenhas J; Taioli E
Carcinogenesis; 2019 Jul; 40(5):651-660. PubMed ID: 30715157
[TBL] [Abstract][Full Text] [Related]
10. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD
J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
[TBL] [Abstract][Full Text] [Related]
11. miR-218 inhibits acute promyelocytic leukemia cell growth by targeting BMI-1.
Wang Y; Sun HH; Sui MH; Ma JJ
Oncol Lett; 2017 Dec; 14(6):8078-8083. PubMed ID: 29344251
[TBL] [Abstract][Full Text] [Related]
12. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
13. CD34(+) therapy-related acute promyelocytic leukemia in a patient previously treated for breast cancer.
Savooji J; Shakil F; Islam H; Liu D; Seiter K
Stem Cell Investig; 2016; 3():7. PubMed ID: 27358899
[TBL] [Abstract][Full Text] [Related]
14. Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3).
Zhang T; Westervelt P; Hess JL
Mod Pathol; 2000 Sep; 13(9):954-61. PubMed ID: 11007035
[TBL] [Abstract][Full Text] [Related]
15. C-Myc functions as a competing endogenous RNA in acute promyelocytic leukemia.
Ding Y; Wang ZC; Zheng Y; Hu Z; Li Y; Luo DF; Wang SY
Oncotarget; 2016 Aug; 7(35):56422-56430. PubMed ID: 27486764
[TBL] [Abstract][Full Text] [Related]
16. The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors.
Zeng H; Yin LD; Li P; Yuan YH; Guan CY; Xie T; Zhang QG
Hematology; 2016 Oct; 21(9):513-9. PubMed ID: 27077772
[TBL] [Abstract][Full Text] [Related]
17. Addressing the room for improvement in management of acute promyelocytic leukemia.
Nørgaard JM; Friis LS; Kristensen JS; Severinsen MT; Mølle I; Marcher CW; Møller P; Schoellkopf C; Nielsen OJ; Preiss BS; Andersen MK; Kjeldsen E; Medeiros BC; Østgård LSG;
Eur J Haematol; 2019 Jun; 102(6):479-485. PubMed ID: 30887583
[TBL] [Abstract][Full Text] [Related]
18. The molecular biology of acute promyelocytic leukemia.
Slack JL; Gallagher RE
Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
[TBL] [Abstract][Full Text] [Related]
19. Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1.
Osumi T; Watanabe A; Okamura K; Nakabayashi K; Yoshida M; Tsujimoto SI; Uchiyama M; Takahashi H; Tomizawa D; Hata K; Kiyokawa N; Kato M
Genes Chromosomes Cancer; 2019 Nov; 58(11):820-823. PubMed ID: 31350930
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
Ng HY; Wan TS; So CC; Chim CS
J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
